We are live on
!
Find out more
AC
Axon Capital Portfolio holdings
AUM
$69.3M
This Fund
S&P 500
This Quarter
Est. Return
+6.23%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$47.9M
AUM Growth
+$285K
(+0.6%)
Cap. Flow
-$2.71M
Cap. Flow
% of AUM
-5.66%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
1
Reduced
5
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$6.97M |
| 2 |
PTC Therapeutics
PTCT
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$6.41M |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.12M |
| 4 |
TSG
The Stars Group Inc.
TSG
|
+$1.07M |
| 5 |
PLYA
Playa Hotels & Resorts
PLYA
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.77% |
| 2 | Communication Services | 39.42% |
| 3 | Consumer Discretionary | 12.89% |
| 4 | Financials | 7.93% |
Similar funds
YEPX
WG
FWA
VIM
CCM
FCI
RL
SCH
Axon Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Axon Capital held 8 positions worth $47.9M, up 0.6% from $47.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Axon Capital withdrew a net $2.71M in Q2 2019, reducing 5 holdings. Its largest reduction was Centene, cutting an estimated $6.41M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 31% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Axon Capital opened a new position in Humana worth $7.3M.
- Axon Capital's largest Q2 2019 buy was Humana: 27,500 shares worth $7.3M.
- Axon Capital added most to PTC Therapeutics in Q2 2019, an estimated $1.99M increase.
- Axon Capital's biggest Q2 2019 reduction was Centene, cutting an estimated $6.41M.
- Axon Capital's ten largest holdings make up 100% of its $47.9M portfolio in Q2 2019.
- Axon Capital opened 1 new position and closed 0 in Q2 2019.
- Axon Capital's portfolio value rose 0.6% quarter-over-quarter to $47.9M.
Based on Axon Capital's 13F filing for Q2 2019, filed 14 Aug 2019.